AstraZeneca Makes Potential $1B Cell Therapy Play in EsoBiotec Buy
AstraZeneca has recently been investing heavily in the cell therapy space, including two acquisitions for TeneoTwo and Gracell Biotechnologies.
AstraZeneca Makes Potential $1B Cell Therapy Play in EsoBiotec Buy Read More »
